Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease

BACKGROUND: Empagliflozin exerted positive cardiorenal effects in the EMPA-KIDNEY trial; this study reports active trial plus post-trial data. METHODS: In this trial, patients with an estimated glomerular filtration rate 20-<45; or 45-<90mL/min/1.73m(2) and urinary albumin-to-creatinine ratio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:N Engl J Med
Autors principals: Herrington, William G., Staplin, Natalie, Agrawal, Nikita, Wanner, Christoph, Green, Jennifer B., Hauske, Sibylle J., Emberson, Jonathan R., Preiss, David, Judge, Parminder, Zhu, Doreen, Dayanandan, Rejive, Arimoto, Ryoki, Mayne, Kaitlin J., Ng, Sarah Y.A., Sammons, Emily, Hill, Michael, Stevens, Will, Wallendszus, Karl, Brenner, Susanne, Cheung, Alfred K., Liu, Zhi-Hong, Li, Jing, Hooi, Lai Seong, Liu, Wen, Kadowaki, Takashi, Nangaku, Masaomi, Levin, Adeera, Cherney, David Z.I, Maggioni, Aldo P., Pontremoli, Roberto, Deo, Rajat, Goto, Shinya, Rossello, Xavier, Tuttle, Katherine R., Steubl, Dominik, Massey, Dan, Brueckmann, Martina, Landray, Martin J., Baigent, Colin, Haynes, Richard
Format: Artigo
Idioma:Inglês
Publicat: 2024
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616743/
https://ncbi.nlm.nih.gov/pubmed/39453837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2409183
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars